{
  "type": "hyp",
  "text": "In the HT29 tumor model treatment response to vandetanib (50 mg/kg/day Monday-Friday for 2 weeks) was greatest in xenografted tumors derived from the highest VEGF-expressing cell clones.\n",
  "self": {
    "NER": {
      "answers": [
        "50 mg/kg/day",
        "Monday-Friday",
        "2 weeks"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the daily dose of vandetanib?",
          "When was the treatment response greatest in HT29 tumors?",
          "How long did vandetanib last?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "the HT29 tumor model treatment response",
        "vandetanib",
        "50 mg/kg/day",
        "2 weeks",
        "xenografted tumors",
        "the highest VEGF-expressing cell clones"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was the most effective treatment for HT29 tumors?",
          "What drug was most effective in HT29 tumors?",
          "What is the daily dose of vandetanib?",
          "How long did vandetanib last?",
          "What type of tumors had the greatest response to vandetanib?",
          "What type of tumors were most affected by vandetanib?"
        ]
      }
    }
  },
  "asked": {
    "What is the daily dose of vandetanib?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "50 mg/kg/day",
        "answerability": 0.9972240328788757,
        "ground_truth": {
          "50 mg/kg/day": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "When was the treatment response greatest in HT29 tumor models?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "xenografted tumors derived from the highest VEGF-expressing cell",
        "answerability": 0.9273653030395508,
        "ground_truth": {
          "Monday-Friday": {
            "bertscore": 0.5474791526794434,
            "f1": 0
          }
        }
      }
    },
    "How long did vandetanib last?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "2 weeks",
        "answerability": 0.9644669890403748,
        "ground_truth": {
          "2 weeks": {
            "bertscore": 0.9999998807907104,
            "f1": 1.0
          }
        }
      }
    },
    "What was the most effective treatment of vandetanib?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "50 mg/kg/day",
        "answerability": 0.704354465007782,
        "ground_truth": {
          "the HT29 tumor model treatment response": {
            "bertscore": 0.6131303310394287,
            "f1": 0
          }
        }
      }
    },
    "What drug was most effective in the HT29 tumor model?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "vandetanib",
        "answerability": 0.9942415356636047,
        "ground_truth": {
          "vandetanib": {
            "bertscore": 1.000000238418579,
            "f1": 1.0
          }
        }
      }
    },
    "What type of tumors showed the greatest response to vandetanib?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "xenografted",
        "answerability": 0.989065945148468,
        "ground_truth": {
          "xenografts": {
            "bertscore": 0.9264569878578186,
            "f1": 0
          }
        }
      }
    },
    "What was the most effective treatment for HT29 tumors?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "vandetanib",
        "answerability": 0.951179563999176,
        "ground_truth": {
          "the highest VEGF-expressing cell clones": {
            "bertscore": 0.6219635605812073,
            "f1": 0
          }
        }
      }
    }
  }
}